Vivos Therapeutics Inc

Vivos Therapeutics: promising sleep‑apnea tech faces steep stock volatility, negative P/E and limited U.S. market reach—investors weigh risk vs. breakthrough potential.

Vivos Therapeutics, a high‑growth sleep‑apnea tech firm, sees a steep stock drop amid a $4.64 M capital raise—can it turn losses into lasting value?

Vivos Therapeutics’ Q3 2025 earnings reveal rising revenue and investor confidence while the company pushes innovative sleep apnea tech, promising better patient outcomes.

Vivos Therapeutics, Inc. is a pioneering medical technology company dedicated to developing innovative solutions for sleep-disordered breathing and obstructive sleep apnea, with a mission to enhance patient care and quality of life.

Vivos Therapeutics, Inc. is a pioneering medical technology company developing innovative solutions for sleep-disordered breathing and obstructive sleep apnea, with a mission to enhance the quality of life for millions of patients.

Vivos Therapeutics, Inc. is a medical technology firm pioneering innovative solutions for sleep-related respiratory disorders, aiming to improve the quality of life for millions of patients worldwide.

Vivos Therapeutics, Inc. is a medical technology firm pioneering innovative solutions for sleep-related respiratory disorders, aiming to improve the quality of life for millions of patients worldwide.